Colorectal Cancer 2018
EuroSciCon invites the participants from all over the world to attend the 3rd Edition of International Conference on Colorectal Cancer 2018, this Colorectal Cancer Conference will assemble recent researches & findings, oral talks, poster presentation and exhibition in colorectal cancer, colorectal cancer therapies and other issues in colorectal cancer research and its science from October 11-12th, 2018 in imperial Capital Zurich-Switzerland.The motive of this cancer conferences is "A scientific approach to enlighten about diagnosis and therapeutics in colorectal cancer" which will provide an international platform for discussion of present and future challenges in various kind of its genetical and immunological diseases, disorder, symptoms & analysis regard to colorectal cancer along with education and expertise meeting on oncology conferences.
The Colorectal Cancer Conference 2018 includes international attendee workshops, lectures,exhibition,debates, meetings including a vulnerable registration area, and to ease up and delight. Colorectal cancer educationist can join the EuroSciCon as an international member to receive discounts on registration. So, come and accompany this wonderful oncology conferences with preeminent experts and unified professionals from October 11-12th 2018,in Zurich-Switzerland to keep up with the promptly expedite pace of change that is already having an impact on the field of Colorectal cancer, and will rectify eventually in this cancer conferences.
Why to visit the colorectal cancer conference 2018?
This oncology conferences 2018 on colorectal cancer is the evidences/study done towards the treatment of colon, bowel, rectal cancer. Like lungs, breast, and cervical cancer colorectal cancer is fourth most deadly cancer which at least effect 1.5 billion people every year. To share the knowledge and gain the ideas regarding colorectal cancer can prove worthy to the medical research field especially to the oncology research because of the fast food lifestyle leading to diabetes and obesity the main cause for increase of colorectal cancer is to be discussed in this cancer conferences.
Cancer conferences on colorectal cancer 2018 will congregate the unified spectrum of the colorectal cancer, regarding its prevention, analysis & cure, treatment, side effects of prescription, supportive care, quality-of-life, and survivorship issues in the field of colorectal cancer. It will include the use of technologies, both in the diagnosis and treatment against colorectal cancer. The Oncology conference 2018 on colorectal cancer will provide clinicians and researchers with a platform to publicize their subjective experiences to a huge public as well as to know interesting cases regarding colorectal cancer come across by colleagues all over the world.
The Cancer conferences 2018 on colorectal cancer will promote the recent discoveries/advances performed towards the treatment of colorectal cancer, with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of colorectal cancer. A perfect platform to share knowledge and to acquire the seamless treatment procedures in this oncology conferences.
Zurich an imperial-metropolitan city of Switzerland was discovered by romans with German and Swiss German as common language comes under Europe with many beautiful museums, galleries, a hub of different transportation. Religious yet modernized global city with quality & quantity living of life. The wealthiest City of Europe with a population of 2.0 million. Famous for the food, culture, fashion, festivals, cultures, celebration also makes it a tourist attraction along with the pleasant weather. Zurich is the home of vital museums and cultural institutions and to truly understand Zurich you must immerse yourself in the city’s artistic culture. The dream destination for millions of people each year. A proud moment to introduce the 3rd Edition of International Colorectal cancer conference to the imperial city Zurich-Switzerland.
An excellent oppurtunity to share and gain knowledge , ideas, & researches in the Oncology conferences 2018 on Colorectal Cancer, to understand it and try spreading the prevention which is only possible with the support of all of you, which will be happening in this cancer conferences.
- Associate professors
- Medical oncologist
- Radiation oncologist
- Health care professionals
- Physician assistants
- Oncology nurses
- Social workers
- Research scholars & students.
Sessions & Tracks
Cancer can occur anywhere in the body. The continuous growth of tumor cells can affect organ which can be lung, prostate, colon, rectum, stomach, liver, cervix, breast. Cancer are often described by the body part that they originated from. However, some body parts contain multiple types of tissue, so to be precise, cancer can be additionally classified by the type of cell that the tumor cells originated from. The type of cancer a person has needed to be known properly as diverse types of cancer can behave very differently and respond to different treatments. In that colorectal cancer is one of the organ specific cancer which begins with polyps and can be seen on the inner lining of colon or rectum and are further categorised based on polyps.
- Adenomatous Polyps
- Hyperplastic Polyps
- Bowel Cancer
- Rectal cancer
- Colon cancer
- Gastrointestinal stromal tumors (GISTs)
Colorectal cancer are associated with hints or syndromes knowing them early can reduce the risk and can be prevented. One of the early clue of colorectal cancer is bleeding. The colorectal cancer depends on the position of the tumor in the bowel, and whether it has spread anywhere in the body. A routine screening must be carried to detect the presence of the colorectal cancer tumor and especially for aged people above 50 it is considered bit sensitive as they are more prone to get this disease because of the weak bowel system.
- Change in bowel habits
- Blood in the stool
- Abdominal pain
- Weight loss
The colorectal cancer varies in different world regions. The highest colorectal cancer is noted in industrialized countries, and in developing countries Colorectal cancer is not diagnosed high. The number of colorectal cancer cases increases in countries that undergo rapid economic transformations and adopt a Western lifestyle. This observation strongly suggests that one of the key mechanisms of carcinogenesis of colorectal cancer is associated with environmental factors. Current data suggest that lifestyle modification by addition of proper diet which is rich in vegetable, vitamins, fibers and reduction in red meat and fat, regular physical activity and exercise and maintaining an appropriate body weight and may lead to reduce colorectal cancer risk. Some risk factors include
- Alcohol consumption
- Bowel diseases
All colorectal cancers induced by a heritable mutation – a genetic change that can be passed on from parent to child. The major subtypes of hereditary colon cancer and some rare conditions include an inherited risk for colorectal cancer. In some families if there is a strong hint or symptoms present genetically from ancestors, may pass that mutated gene from parent to offspring. The disease susceptibility of these families occurs randomly or by hereditary mutations which might not been observed that easily because mutations occur in gene like APC, KRAS, TP53, SMAD4 THAT that lead cells to grow uncontrollably resulting in Colorectal Cancer. Genetic counselors and physicians can help understand colorectal cancer risk and type .
- History & family background
- Familial adenomatous polyposis (FAP)
- Hereditary nonpolyposis colorectal cancer (HNPCC)
- Attenuated familial adenomatous polyposis (AFAP)
- Irritable Bowel Disease (IBD)
- Inherited syndrome
- Lynch Syndrome
- Mutation Associated Polyposis
- Peutz Jeghers Syndrome
- MUTYH Associated Polyposis
All cancer treatment is based on stages as each stage has their own variation. In Colorectal Cancer, this variation or treatment is determined by stages only which is divided to ‘TNM’-TUMOR, NODE, METASTASIS combination of this three will determine the stage of Colorectal Cancer which initially begins at stage 0 to stage 5. Tumor varies from T0-T4B, similarly for the node also NX to N2B and metastasis is MX-M1B.
- Stage 0
- Stage I
- Stage II A
- Stage II B
- Stage II C
- Stage III A
- Stage III B
- Stage III C
- Stage IV A
- Stage IV B
Colorectal Cancer is the fourth highest effected cancer which approximately takes around 85,700 life every year. The cancer which invades the bowel system or intestinal part including the rectum, colon etc. Mostly effects the developed countries because of the modern lifestyle with change in living environment, food and aged people who have higher chances of being the victim of colorectal cancer. Screenings are carried out to determine the colorectal tumor cells presence or absence. Like other cancer disease Colorectal Cancer's symptoms are not easily observed and quite difficult in aged people too .So continous screening will be helpful in determing the presence of the tumor.
- High-sensitivity fecal occult blood tests (FOBT)
- Stool DNA test (FIT-DNA)
- Double contrast barium enema
In Colorectal Cancer surgery is where the tumor is removed makes it the most common diagnostic method for all stages of colon cancer. The doctor may remove the tumor without cutting through the abdominal wall. Doctor may put a tube with a cutting tool through the rectum into the colon and cut the tumor or remove it from the effected region. If the tumor is larger, the doctor will perform a partial surgery where removing the tumor and a small amount of healthy tissue around it. The doctor may sew the healthy parts of the colon together. The doctor takes to examine the lymph node near the colon under a microscope to see whether they contain cancer.
- Laparoscopic surgery
- Colostomy for rectal cancer
- Radiofrequency ablation (RFA) or cryoablation
- local excision
- Ablation & Embolization
Radiation therapy in Colorectal Cancer is a treatment that uses high energy X-rays or other types of radiation to kill cancer cells and stops them from further growing. There are types of radiation therapy for colorectal tumor in which either a machine is used outside the body to send radiation toward the cancer or uses a radioactive substance sealed in needles, wires, or catheters that are placed directly into or near the tumor .
- External-beam radiation therapy
- Stereotactic radiation therapy
- Intraoperative radiation therapy
Chemotherapy is a treatment that uses various drugs and medication to pause the growth of tumor cells, by destructing or by stopping the division of tumor cell. The chemotherapy taken by mouth or injected into vein or muscle, the drugs reach the bloodstream and cancer cells throughout the body. Chemotherapy can also be done through applying the drugs directly on effected region or via cerebral fluid. Only a small amount of the drug reaches other parts of the body. The way chemotherapy is given depends on the type and stage of the colorectal cancer. There are different chemotherapy drugs for treating colorecatal cancer.
- Capecitabine (Xeloda)
- Irinotecan (Camptosar)
- Trifluridine/tipiracil (TAS-102, Lonsurf)
- 5-FU with leucovorin and oxaliplatin (called FOLFOX)
- Systemic Chemotherapy
- Regional Chemotherapy
- Adjuvant Chemothrapy
- NeoAdjuvant Chemotherapy
The treatment that uses drugs or other substances to identify to target and attack tumor cells without harming normal cells is target therapy. For colon cancer, different type of target therapies is used like monoclonal antibodies, toxins and drugs approved by medical association for treatment of colorectal cancer which can identify tumor cells and block them from further growing or by further dividing and used to treat colorectal tumors that has spread to other regions of the body. The drug blocks the action of certain proteins, including vascular endothelial growth factor and cell signalling pathways.
- Anti-angiogenesis therapy
Immunotherapy treatments can act as a catalyst or healer for ideal immunologic conditions that could increase the lives of colorectal cancer patients. The recent development of certain Immune-tool helps to classify tumors, identify the rate of survival in patients with colorectal cancers, which provides a precise diagnosis information that can improve the clinical decisions and treatment of patient. It is believed that if immunotherapy is used as cure not only in colorectal cancer but for other type of cancer diseases it will be a ray of hope for future medical research in diagnosing the disease early and to cure it.
- Biological response modifiers
- Colony stimulating factors
- Tumor vaccines
- Monoclonal antibodies
Exercise may be advised in the future as secondary therapy to colorectal cancer survivors. Exercise may reduce colorectal cancer. Results by doing exercise proved to be beneficial to the patients . A measure of exercise, detected a reduction in colorectal cancer mortality. Exercise benefits survival may be involved in immune and inflammation pathways. Oxidative balance may also reduce the colorectal cancer. Other solutions may involve metabolic hormone and steroid hormones. Palliative care is medical care which focuses on treatment from serious illness and improving quality of life. Its recommended for person who has advanced colon cancer or has significant symptoms, it may be beneficial to improve symptoms, anxiety and preventing admissions to the hospital.
Experiment proofs suggest that lactic acid bacteria may be protective against the development and progression of colorectal cancer through several mechanical functions like antioxidant, immune-modulation, programmed cell death and epigenetic modification of cancer cells. Large-scale genome sequencing studies have been done to identify mutations in colorectal cancer patients' genome.
- Mouse model of colorectal cancer
- The cancer genome Atlas
- The colorectal cancer atlas integrating genomic and proteomic data pertaining to colorectal cancer tissues and cell lines.
- Aspirin Drug
- Oncotype Dx Screening
- Colon Cancer Assay
- Coloprint Dx
- Immune Checkpoint Inhibitors
- Cancer Vaccines
- Hyperthermic Intraperitoneal Chemotherapy
Globally more than 1 million people get colorectal cancer every year. Colorectal cancer is more common in developed countries. Globally its 10-fold highest rates in Australia, Europe and USA. Colorectal cancer is the cause of cancer occurrence and death for men and women in the United States where an estimated 141,210 cases were diagnosed in 2011. Based on rates half of US men and women born today will be diagnosed with colorectal cancer, the median age at diagnosis for cancer of the colon and rectum in the US was 69 years of age. In United Kingdom & Australia colorectal cancer is fourth common disease as part of western and modern lifestyle and adapting new mannerism of eating habit which avoids nutritious content in food but involve more amount of fat content, lacking exercise and addicted to high consumption of alcohol and smoking leads to Colorectal Cancer in the developed countries compare to developing countries and making Colorectal Cancer a common health issue not only among old age people but among the young generation and even children also.
Colorectal Cancer Diagnostics Market
The global market size of CRC diagnostics is expected to reach $8.1 billion by 2024 from $4.1 billion in 2015 and is predicted to raise at a CAGR of 8.8% over the forecast period. Growing prevalence of Colorectal cancer, gastrointestinal cases, constant technological innovations in diagnostics, and increasing requirement for effective screening tests are some of the main factors prompting the demand for screening tools across the world. Rising awareness and supportive government enterprises are some other factors that are participating to increase the growth of the sector during the forecast period. The global Colorectal Cancer diagnostics market is divided based on technology, application, and region. Rise in aging population and many bowel diseases cases, Obesity, Diabetes, alcohol consumption & smoking are likely to create huge opportunity for rise in CRC diagnostics.\
ESO - European School of Oncology | Kharkiv National Medical University | Medical University – Plovdiv | Medical University – Pleven | Bukovinian State Medical University | KU Leuven – University of Leuven, Belgium | Technical University of Munich | Humboldt University of Berlin | University of Amsterdam | Erasmus University Rotterdam | Leiden University | RWTH Aachen University | University of Groningen | Utrecht University | University of Tübingen | Yerevan State Medical University | University of Copenhagen | Maastricht University | Medical University of Vienna | University of Milan | University of Barcelona
Stanford University | Johns Hopkins School of Medicine | UCSF School of Medicine | Duke University | Yale School of Medicine | Harvard Medical School | UNC School of Medicine | UT Southwestern Medical School | The University of Chicago Pritzker School of Medicine | Maryland School of Medicine | University of Cincinnati Academic Health Center | University of Wisconsin School of Medicine | University of Minnesota Medical School | Stony Brook School of Medicine | Vermont College of Medicine | Wayne State School of Medicine | Emory University: School of Medicine | University of Utah School of Medicine | Vanderbilt University | Penn State Hershey College of Medicine | Alabama School of Medicine | UMASS School of Medicine | Rutgers New Jersey Medical School | Oklahoma College of Medicine
University of Tokyo | National University of Singapore | Kyoto University | University of Hong Kong | Peking University | Seoul University | National Taiwan University | Osaka University | Tsinghua University | Duke-NUS Medical School | Asian Medical Institute | International Medical University | Taipei Medical University | Allianze University College of Medical Sciences | Mahidol University | Herat University Faculty of Medicine | Karaganda State Medical University | Perdana University Graduate School of Medicine | Chongjin Medical University | Nanyang Technological University
Makerere University | University of Ghana At Legon | University of Nairobi | University of Ibadan | University of Botswana | University of Lagos | Cheikh Anta Diop University | University of Dar Es Salaam | University of Cape Town | Stellenbosch University | University of Pretoria | Cairo University | University of Witwatersand | University of Kwazulu-Natal | University of Western Cape | Mansoura University | University of Johanessburg | Orotta School of Medicine | Addis Ababa University | Aga Khan University Medical School | Egerton University Medical School | University of Malawi College of Medicine | Ambrose Alli University | Walter Sisulu University | Busitema University School of Medicine
Chiro Hospital Group, Spain | Cyberknife Center Hamburg, Germany | Vithas Xanit International Hospital, Spain | Anadolu Medical Center, Turkey | Hygeia Hospital, Greece | Neolife Oncology Center, Turkey | Medipol Mega University Hospital, Turkey | Teknon Medical Center, Spain | Ruber International Hospital, Spain | British Hospital Lisbon XXI, Portugal | Clinic of L'Alma, France | Clinic Hirslanden & Klinik Im Park, Switzerland | Sanitas Hospitals, Spain | Sant Joan de Déu-Barcelona Children's Hospital, Spain | HM Hospitals, Spain | Koc University Hospital, Turkey | University Hospital HM Montepríncipe, Spain | Medicana Healthcare Group Turkey | University Hospital HM Sanchinarro, Spain | Heidelberg University Hospital, Germany | Hisar Intercontinental Hospital, Turkey | Klinikum Stuttgart, Germany | Nisa Pardo de Aravaca Hospital, Spain | Liv Hospital, Turkey | Hospital Quirón Valencia, Spain
University of Texas MD Anderson Cancer Center, Houston | Memorial Sloan Kettering Cancer Center, New York City | Mayo Clinic, Rochester, Minnesota | Dana-Farber/Brigham and Women's Cancer Center, Boston | UCLA Medical Center, Los Angeles | Moffitt Cancer Center and Research Institute, Tampa, Florida | Seattle Cancer Care Alliance/University of Washington Medical Center | Cleveland Clinic | Johns Hopkins Hospital, Baltimore | UCSF Medical Center, San Francisco | Massachusetts General Hospital, Boston | Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia | Stanford Health Care-Stanford Hospital, California | Northwestern Memorial Hospital, Chicago | Barnes-Jewish Hospital/Washington University, St Louis | University of North Carolina Hospitals, Chapel Hill | New York–Presbyterian University Hospital of Columbia and Cornell, New York City | USC Norris Cancer Hospital-Keck Medical Center of USC, Los Angeles | Wake Forest Baptist Medical Center, Winston-Salem, North Carolina | City of Hope, Duarte, California
Rambam Medical Center, Israel | Gleneagles Global Hospitals, India | Bangkok Hospital Pattaya, Thailand | Sourasky Medical Center, Israel | Mahkota Medical Centre, Malaysia | Apollo Hospital Chennai, India | Gleneagles Medical Centre Penang, Malaysia | Sunway Medical Centre, Malaysia | Bumrungrad Hospital, Thailand | National Cancer Centre, Singapore | KPJ Ampang Puteri Specialist Hospital, Malaysia | BNH Hospital, Thailand | Mount Elizabeth Hospital, Singapore | National University Hospital, Singapore | Rabin Medical Center, Israel | Hadassah University Medical Center, Israel | St. Luke's Medical Center, Philippines | KPJ Damansara Specialist Hospital, Malaysia | Herzliya Medical Center, Israel | Raffles Hospital, Singapore | Assuta Hospital, Israel | Sheba Medical Center, Israel
Hummingbird Cancer Centre, Cape Town, South Africa | Life Healthcare Hospital Group, South Africa | Ahmed Kathrada Private Hospital | DavidAnderson Hospital | Hummingbird Cancer Centre, Cape Town, South Africa | UCT Private Academic Hospital, Cape Town, South Africa | Langenhoven Drive Oncology Centre | Vincent Pallotti Oncology Centre | Solway Oncology Hospital | Constantiaberg Oncology Hospital | Vergelegen Oncology Hospital | African Cancer Center | NutriTherapy, South Africa | PaulRuff,Md, Johannesburg/Soweto, South Africa | Sandton Oncology Centre, South Africa| Rondebosch Oncology Centre | Outeniqua Oncology Unit | Border Oncology Unit | Lowveld Oncology Unit
Asian Clinical Oncology Society: ACOS | Asian Society for Neuro-Oncology |Asian Society of Gynecologic Oncology | Asian Pacific Journal of Cancer Prevention| Australasian Lung Cancer Trials Group | Black Sea Countries Coalition on Breast and Cervical Cancer Prevention | Cancer Therapeutics Research Group | Asian Fund for Cancer Research | Asian Cancer Foundation | Asian and Pacific Federation of Organizations for Cancer Research and Control
Africa Cancer Foundation | African Cancer Registry Network | African Organisation for Research and Training in Cancer | African Journal of Cancer | Mediterranean Oncology Society | Oncology for Africa ONLUS – Afron | World Health Organisation - Africa Region | African Women’s Cancer Awareness Association | Afrox - Improving Cancer Care in Africa | CHOC Childhood Cancer Foundation South Africa | Breast Cancer Initiative East Africa (BCIEA) | African Cancer Registry Network
27th International Oncology research Conferences and Cancer Stem Cells Conferences May 10-12, 2018 Frankfurt, Germany 23rd International Cancer Research Conferences & Pharmacology Conferences March 26-27, 2018 Edinburgh, Scotland; 21st Global Experts Oncology Conferences & Cancer Case Reports conferences February 26-27, 2018 Paris, France; 2nd International Epigenetics Conferences and Chromatin Conferences November 06-08, 2017 Frankfurt, Germany; 2nd World Medical Imaging Conferences and Clinical Research Conferences September 11-12, 2017 Paris, France; 28th Euro Cancer Science Conferencesand Cancer Therapy Conferences August 09-10, 2018 Madrid, Spain; International Oncology Conferences and Diagnostics Conferences August 28-29, 2017 Brussels, Belgium; 9th Biomarkers Conferences December 07-08, 2017 Madrid, Spain; 3rdInternational Nuclear Medicine Conferencesand Radiation Therapy Conferences March 26-27, 2018 Edinburgh, Scotland; 9th InternationalLeukemia Conferences and Hematologic Oncology Conferences October 05-06,2017 London; 4th World cancer conferences and Cancer Prevention Methods Conferences April 19-21, 2018 Valencia, Spain; NCRI Cancer Conferences November 05-08, 2017 Liverpool, UK; Global Cancer Therapy ConferencesAugust 07-09, 2017 Frankfurt, Germany; 11th European Breast Cancer Conferences Mar 21- 23,2018 Barcelona, Spain ; In vivo model of metastasis Conferences November 27-29, 2017 Berlin, Germany; 25th Biennial European Association for Cancer Research ConferencesJune 30–July 3 2018 Amsterdam
Global Oncology conferences & Cancer conferences March 14-16, 2018 Singapore; 18th Asia Pacific Prostate Conferences Aug 30 - Sep 02, 2017 Melbourne; 32nd International Oncology Nursing Conferences and Cancer Care Conferences Sep 13-14, 2017 Singapore; 43rd Turkish Society of National Hematology Conference November 17-19, 2017 Antalya, Turkey; ESMO Asia Cancer Conference November 17-19, 2017 Singapore; 26th World Cancer Conference November 27-28, 2017 Dubai, UAE; 28th International Society Of Blood Transfusion Conference November 25-18, 2017 Guangzhou , China; Global Oncology Conferences and Radiology Conferences April 16-17,2018 Dubai, UAE; World Hematology Conferences and Medical Oncology Conferences May 28 - 30, 2018Osaka, Japan
International Oncology Conference November 27-28, 201 Georgia, USA; International Cancer Biology Conferences and Therapeutics Conferences October 23-24, 2017 Ontario, Canada; 7th World Breast Cancer Conferences November 1-2, 2017 Toronto, Canada; International Oncology Conferences and Cancer Therapeutics Conferences October 30 - November 01, 2017 Illinois, USA; 59th American Society Of Hematology ConferenceDecember 9-12, 2017 Atlanta, United States; 11th International Hematology Conferences on & Hematological Oncology Conferences November 08-09, 2017 Las Vegas, Nevada, USA; International Oncology Conference and Radiology Conferences October 25, 2017 Las Vegas, United States; 4th Annual on Gynecologic Oncology Conferences July 18-19, 2018 Atlanta, USA
AORTIC International Conferences November 7-10, 2017 Kigali, Rwanda; ESMO Africa Cancer Conference February 14-16, 2018 Cape town, South Africa; SASCRO SASMO Cancer Conferences Sandton Convention Centre, South Africa; SASCeTS & Clinical Haematology Society Cancer Conference November 4, 2017 Cape town, South Africa
CA - A Cancer Journal for Clinicians | Nature Reviews Cancer | The Lancet Oncology | Journal of Clinical Oncology | Nature Reviews Clinical Oncology | Annals of Oncology | Cancer Research | Cancer Discovery | Clinical Cancer Research | Neuro-Oncology | Journal of Thoracic Oncology | International Journal of Radiation Oncology Biology Physics | Radiotherapy and Oncology | Cancer and Metastasis Reviews | Journal of Cancer Survivorship | Psycho-Oncology | Seminars in Radiation Oncology | Current Opinion in Oncology | Critical Reviews in Oncology/Hematology | Journal of Hematology and Oncology | Journal of the National Cancer Institute
Sol Et Salus Spa | Sanera Pharmaceuticals | Aromics | Kuzey Pharma | Remedica Ltd | Azanta | Bone Therapeutics | Iteos Therapeutics | Regenesys (Athersys) | Linatech| Dandrit Biotechnology |Dako (Agilent) | H-Immune | Pierre Fabre |Oncodesign | Anagenesis Biotechnologies | Apcure | Ose Immunotherapeutics | Aratinga Bio | Genclis | Vaxon Biotech | Ibt Bebig
Gilead Sciences, Inc. | AMGN | Biogen, Inc. | Celgene Corporation | Regeneron Pharmaceuticals, Inc. | Alexion Pharmaceuticals Inc. | Vertex Pharmaceuticals| Illumina | BioMarin Pharmaceutical Inc. | Agilent Technologies, Inc. | Flatiron Health | Epizyme | ARMO Biosciences | Guardant Health | Tesaro | bluebird bio | effector Therapeutics | Mersana Therapeutics | CytomX Therapeutics | Edico Genome | Raze Therapeutics | G1 Therapeutics | Agenus Inc. | Personal Genome Diagnostics (PGD) | VentiRx Pharmaceuticals
Hanmi Pharmaceutical's New Bio Manufacturing Plant | Boehringer Ingelheim | WuXi Biologics’ Perfusion Biologics | Pfizer’s Global Biotechnology Centre | GlaxoSmithKline’s (GSK) Pharmaceutical Inc. | Affymetrix Inc | Daiichi Pharmaceutical Company | Merck Serono’s Pharmaceuticals | Novartis Institute of BioMedical Research | Searle Pharma Medication Production Plant | Shionogi Pharmaceutical Research Facility | Taiyo Pharmaceutical Industry | WuXi Biologics’ Perfusion Biologics | Nippon Shinyaku Corporation | Medlac Pharmaceutical Plant | Lonza Niacinamide Production Facility | Kemwell Biopharmaceuticals Inc. | GE Healthcare Shanghai Pharmaceutical Manufacturing Plant | AstraZeneca Pharmaceutical Manufacturing Plant | Alcon Pharmaceutical Facility | Beike Biotechnology Stem Cell Storage and Processing Facility
AstraZeneca Pharmaceuticals Ltd | Lilly Oncology - Lilly South Africa | Warren Chem Pharmaceuticals | Biotech Laboratories Ltd | Janssen Pharmaceuticals | Axim Pharmaceuticals | Pharmaceutical Industries | Enaleni Pharmaceuticals Ltd | Amalgamated Pharmaceuticals | Dibana Pharmaceuticals | Abbott Laboratories SA | Teva Pharmaceuticals Ltd | Amka Pharmaceuticals Ltd | Medimoc Sarl | Embassy Pharmaceuticals | S D V Pharmaceuticals | Georen Pharmaceuticals Ltd | Allied Drug Company Ltd | Pharmacare International Ltd
Senior Scientific Officer – Bioinformatician jobs | Cellular Assay Development Scientist jobs | Head of Science Media jobs | Senior Scientist - Large Molecule Analysis jobs | Technical Lead - Analytical Services jobs | Head of ECMC Programmed Office jobs | Head of Commercial Partnerships – Bioinformatics jobs | Sr Site Specialist jobs | Regional Manager - Managed Services jobs | Project Research Scientist in Cancer Genetics jobs | Postdoctoral Fellow - CRUK Grand Challenge: Mutographs of Cancer – Cambridge jobs | Senior Research Funding Manager (Discovery Research) jobs | Senior Science Communication Manager jobs | Doctoral candidate (PhD student) in the field of RAS cancer drug development jobs | Senior Oncology Biologist - Cambridge, UK jobs | Protein Scientist jobs | Research Management & Communications Officer jobs | Senior Scientific Officer – Metabolomics jobs | Recruitment Consultant - Life Science - South East jobs | Associate or Full Professor in the Field of Translational Research in Oncology jobs, Geneva, Switzerland | Chief Executive Officer jobs, Strasbourg Cedex, France | Independent Junior Group Leader, Vienna, Austria | Oncology Clinical Trials Fellow, London, UK | Doctor Specialized in Oncology, Belgium | Head of Oncology, Belgium | Clinical Project Manager jobs - Steven age, Hertfordshire | Senior Scientist - Assay Development - Steven age, Hertfordshire | Freelance Editors jobs - Medicine, Life Sciences, Physical Sciences, Psychology | MSc in Cancer Cell Biology – Sussex | Associate Scientist - Steven age, Hertfordshire
Postdoctoral Fellow jobs | Assistant or Associate Professor jobs - Genome Editing & Functional Cancer Genomics | Faculty Positions in Immunology Dana-Farber Cancer Institute/ Harvard Medical School | Tenure-track Assistant Professor jobs Cancer Biology| PhD Studentships | Senior Research Funding Manager jobs | Physician-Scientist, Oncology/Neoplasia jobs | Research Scientist | Research Fellow | Sr Scientist jobs -Belter Center | Faculty Positions in Cancer Research, Harper Cancer Research Institute, University of Notre Dame | Postdoctoral Scholar in Cancer Metastasis and Nanomedicine | Postdoctoral Researcher or Scientist Positions in Cancer and Environmental Stressors | Faculty Member - Biomedical Research | Assistant Professor jobs in Stem Cell and Regenerative Biology | Director, Oncology Promotions / Marketing | HIM - Remote Oncology Data Consultant | R&D Clinical Project Manager jobs - Life Sciences | Medical Director – Oncology | Research Scientist in Immuno-Oncology Job | Clinical Team Leader – Oncology | Senior Director jobs, National Oncology Account Team East | Scientist jobs, Cancer Cell Dependencies, Oncology Research | Director jobs, In-Office Dispensing Operations | Scientist I jobs- Oncology Research | Oncology Medical Science Liaison - Solid Tumors | Director Companion Diagnostics - US Commercial – Oncology | Registered Nurse jobs, Cancer Center of the Rockies PRN | Oncology Clinical Educator jobs - South Carolina | Medical Oncologist/Hematologist jobs
Consultant jobs, Pediatric/Adult Oncology | Consultant jobs in Pediatric Hematology/Oncology | Consultant - | Medical Oncologist jobs | Gynecologist jobs with Laparoscopy Gynecology/Oncology | Surgical Oncologist jobs | Western Qualified Consultant Doctor/s | Radiology Consultant jobs | Senior Consultant Medical Oncologist jobs | Chairman of Oncology jobs | Clinical Oncologist jobs | Pediatric Hematology Oncology Consultant jobs | Consultant jobs in Pediatric Hematology/Oncology & Stem Cell Transplant | Consultant Palliative Care/Arabic speaking jobs | Assistant Consultant jobs Radiation Oncology | Oncology Radiation Therapist jobs | Associate Director jobs, Worldwide HEOR, Oncology | Senior Medical Director jobs - Oncology Development | Regional Medical Science Director jobs – CNS – West | Program Manager and Investigator jobs | Oncology Clinical Director jobs | Research Scientist jobs Breast Cancer Research Team | Post-Doctoral Research Scientist jobs (Head and Neck Cancer)
Medical Manager Oncology jobs | Senior Research Funding Manager jobs | Physician-Scientist jobs Oncology/Neoplasia | Research Scientist jobs | Research Fellow jobs | Senior Pharmacist jobs Backup to Oncology Gatesville Cape Town | Radiotherapist jobs - Oncology |Registered Nurse jobs - Oncology Trained | Customer Service Clerk jobs -Oncology | Insight leader: Oncology jobs | Pre-AUTH Consultant jobs | Pharmacist Assistant jobs Basic Qualified - Glen Marais | Senior Clinical Research Associate jobs | Registered Nurse Oncology jobs | Chemotherapy RN jobs for Cape Town City Centre | Hematology RN jobs for Southern Suburbs | Technician/Research Technologist I jobs, South Africa | Field Worker jobs – PE | General Assistant jobs – PE | Unit Manager jobs – Radiotherapy | Medical Affairs Manager jobs | Enrolled Nurse jobs – Oncology | Permanent Registered Nurse jobs with Oncology trained or experience needed in Pinelands, Cape Town| Head Of Department jobs - Disease Risk Manager
- Zurich City Lake
- Confiserie Sprungli
- Zurich Zoo